Literature DB >> 7819720

Tumor suppressor genes in molecular medicine.

F Hoppe-Seyler1, K Butz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7819720     DOI： 10.1007/bf00227456

Source DB:  PubMed          Journal:  Clin Investig        ISSN： 0941-0198


× No keyword cloud information.
  150 in total

1.  Transcriptional regulation by the retinoblastoma protein.

Authors:  T Kouzarides
Journal:  Trends Cell Biol       Date:  1993-07       Impact factor: 20.808

Review 2.  Human gene therapy.

Authors:  R A Morgan; W F Anderson
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 5.  Second tumors after treatment of childhood malignancies.

Authors:  L L Robison; A Mertens
Journal:  Hematol Oncol Clin North Am       Date:  1993-04       Impact factor: 3.722

6.  Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13.

Authors:  A Banerjee; H J Xu; S X Hu; D Araujo; R Takahashi; E J Stanbridge; W F Benedict
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

7.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.

Authors:  A K Rustgi; N Dyson; R Bernards
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

8.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

9.  Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Authors:  A S Sarkis; G Dalbagni; C Cordon-Cardo; Z F Zhang; J Sheinfeld; W R Fair; H W Herr; V E Reuter
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

10.  Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.

Authors:  P S Huang; D R Patrick; G Edwards; P J Goodhart; H E Huber; L Miles; V M Garsky; A Oliff; D C Heimbrook
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272
View more
  3 in total

1.  APC and K-ras gene mutation in aberrant crypt foci of human colon.

Authors:  P Yuan; M H Sun; J S Zhang; X Z Zhu; D R Shi
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.

Authors:  Reshu Gupta; Venkateswara Rao Gogineni; Arun Kumar Nalla; Chandramu Chetty; Jeffrey D Klopfenstein; Andrew J Tsung; Sanjeeva Mohanam; Jasti S Rao
Journal:  Int J Oncol       Date:  2011-02-02       Impact factor: 5.650

Review 3.  Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.